Tech Company Financing Transactions
Dr. B Funding Round
Dr. B closed a $8 million funding round on 8/16/2022. Investors included Founders Fund, Lerer Hippeau and private investors.
Transaction Overview
Company Name
Announced On
8/16/2022
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand access to everyday prescriptions through its new "Visitless Prescription" service.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Undisclosed
Undisclosed, Undisclosed
USA
Undisclosed, Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Covid-19 isn't going away any time soon. Luckily, you can now treat it from home with prescription antiviral medications like Paxlovid and Molnupiravir. These meds help you recover faster and keep you out of the hospital. To get a prescription you'll complete a "visitless" online health assessment, which is then reviewed by a board-certified doctor and sent to your pharmacy if approved. Covid-19 treatments are free at pharmacies. We also offer a no-cost* Covid-19 consult for qualifying patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Cyrus Massoumi
Chief Operating Officer
Michael Hopkins
Chief Technical Officer
Misha Kaletsky
Browse more venture capital transactions:
Prev: 8/16/2022: GrowthSpace venture capital transaction
Next: 8/16/2022: Chamberlain Coffee venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs